Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Polomar Health Services Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Polomar Health Services Inc (PMHS) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q2 2026
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
27,694.64 %
Q2 2026
Net Margin
13.11 %
Q2 2026

Key Findings: Polomar Health Services Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 3M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+92.7% annualized vs trailing 12 months).
  • Peer revenue share: Polomar Health Services Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

PMHS Sales vs. its Competitors, Q2 2026

Polomar Health Services Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/PMHS/competitors
https://api.csimarket.com/api/v1/companies/PMHS/relationships
https://api.csimarket.com/api/v1/companies/PMHS/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Major Pharmaceutical Preparations industry grew revenue 9.0% year over year, combined, vs 27,694.6% for Polomar Health Services Inc. Polomar Health Services Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.

Market Share of the Peer Group, Q2 2026

100%market share
  • Polomar Health Services Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Polomar Health Services Inc and its 0 tracked competitors.

See Polomar Health Services Inc's full market share breakdown »

PMHS Stock Performance relative to its Competitors

PMHS Competitors (weighted) Percent change over the selected range

Polomar Health Services Inc's Comment on Competition and Industry Peers

The Company operates in the online prescription fulfillment market, facing competition particularly in GLP-1 agonist weight loss drugs and erectile dysfunction formulations. Major competitors include Hims/Hers and Ro, which hold significant market share and dispense GLP-1 drugs using traditional vials and syringes requiring manual filling. The Company offers a pre-filled injection pen system as an alternative delivery method. Direct competitors include Levity Healthcare, Inc. and its affiliate ZipHealth, Inc., which provide compounding services and weight loss drug consultations. ZipHealth is licensed in 25 states, plans to expand, and currently does not accept insurance but intends to do so in the future. Levity delivers medication in sterile bottles with syringes for manual filling, while the Company’s pre-filled injector pen system is positioned as a consumer-preferred option.

Polomar Health Services Inc's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
ZipHealth, Inc. Named by the company 85% 2022 to 2026 3
Hims/Hers Named by the company 85% 2022 to 2026 3
Levity Healthcare, Inc. Named by the company 85% 2022 to 2026 3
Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Polomar Health Services Inc's named competitors require a Commercial License.

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.

Get the full CSIMarket dataset: Subscribe API License